Apricus Biosciences (APRI) Receives European Approval for Vitaros® for the Treatment of Erectile Dysfunction
6/10/2013 9:34:00 AM
More...
|
Apricus Biosciences (APRI) Says Vitaros Gets European Approval for Erectile Dysfunction
6/10/2013 7:23:37 AM
More...
|
Apricus Biosciences (APRI) Announces Proposed Public Offering of Common Stock and Warrants
5/23/2013 10:16:17 AM
More...
|
Apricus Biosciences (APRI) Prices $17.1 Million Public Offering of Common Stock and Warrants
5/23/2013 9:35:23 AM
More...
|
Apricus Biosciences (APRI) Provides First Quarter 2013 Corporate Update
5/10/2013 9:20:42 AM
More...
|
Apricus Biosciences (APRI) to Present at 2013 Biotechnology Industry Organization (BIO) International Convention
4/18/2013 11:30:52 AM
More...
|
Apricus Biosciences (APRI) Announces Sale of Non-Core Assets
4/2/2013 7:28:40 AM
More...
|
Apricus Biosciences (APRI) Appoints Richard W. Pascoe as CEO
3/19/2013 7:29:26 AM
More...
|
Apricus Biosciences (APRI) Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012
3/18/2013 12:09:16 PM
More...
|
Apricus Biosciences (APRI) Announces Ceasing of Financing of French Subsidiaries
3/14/2013 10:55:52 AM
More...
|
|